In a battle between real and fake news, Bloomberg reported an hour before the market closed that OpenAI and Oracle had halted plans for the Stargate data center in Texas. Reports also claimed that Nvidia paid $150 million to Crusoe Energy Systems and coordinated with Meta Platforms to lease the site, ensuring incoming customers wouldn’t use GPUs from Advanced Micro Devices. The headline sent shockwaves through the market, causing Nvidia, Oracle, and several AI infrastructure companies — including Taiwan Semiconductor Manufacturing Company — to plunge right before the closing bell. Then came the twist. “Mai Kia, Mai Kia… it’s fake data,” as CNBC later clarified. Oracle confirmed the OpenAI data center plans are still moving forward as scheduled and have not been canceled. But by then, the d

Divorced Last Year, Married Again This Monday? Novo & Hims’ Comeback” $Hims & Hers Health Inc.(HIMS)$   Novo and Hims look like they’re getting married again 💍 after last year’s messy divorce. Hims pops 35% in after hours.  The two companies are expected to announce a new partnership as early as Monday, according to a person familiar with the matter who spoke on condition of anonymity. They were previously together, but Novo abruptly called it quits after Hims refused to stop promoting and selling copycat medications. Now it seems the former couple may be giving love another chance  and Muthu boy is very happy to see the reunion 😊. I wonder… will they order my roti prata from my prata shop? 🥞✨

$Amprius Technologies Operating Inc(AMPX)$   specializes in next-generation lithium-ion batteries featuring silicon anode technology (including their SiCore platform), which delivers significantly higher energy density—up to around 500 Wh/kg in some configurations—compared to traditional graphite-anode batteries. This enables longer runtimes, lighter weight, and better performance in demanding applications like drones/UAVs, electric vertical takeoff and landing (eVTOL) aircraft, electric vehicles (EVs), and light electric vehicles (e.g., e-bikes, robotics). The tech has particular traction in defense, aerospace, and commercial drone sectors due to these advantages. Amprius Technologies (AMPX) could realistically benefit from the ongoing

Big news for weight loss access! Semaglutide patents are expiring soon in countries like India, China, and Brazil (starting March 2026) – meaning super-cheap generic versions are coming!  $Hims & Hers Health Inc.(HIMS)$    Here's why this could be a game-changer for Hims & Hers (and patients worldwide):   Lower Costs As patents expire, raw ingredient (API) prices will crash. If manufacturing drops to ~$3/month, Hims & Hers can slash subscription prices big time – making effective weight loss meds affordable instead of $200–$1,000/month for branded versions. More people can finally access it! Global Expansion Hims & Hers is already pushing internationally (just entered Canada!). With cheap, legal generi